GLAUKOS Corp (GKOS) stock
GKOSNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 7/30215% above fair value
$243.25−1.63 (-0.67%)
Close on Nov 17, 2026Market cap $14.40BP/E –Yield –
Glaukos price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Glaukos's price to sales ratio was 23.7× on Nov 11, 2026, against 13.0× a year earlier. Over the last 5 years it ranged from 6.5× to 23.9×, with a median of 12.8×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 23.7× | +9.9 |
| 2025 | Dec 31, 2025 | 13.8× | −9.1 |
| 2024 | Dec 31, 2024 | 22.9× | +10.2 |
| 2023 | Dec 29, 2023 | 12.8× | +5.4 |
| 2022 | Dec 30, 2022 | 7.3× | +0.2 |
| 2021 | Dec 31, 2021 | 7.1× | −8.4 |
| 2020 | Dec 31, 2020 | 15.5× | +6.6 |
| 2019 | Dec 31, 2019 | 8.9× | −3.0 |
| 2018 | Dec 31, 2018 | 12.0× | +6.1 |
| 2017 | Dec 29, 2017 | 5.9× | −5.4 |
| 2016 | Dec 30, 2016 | 11.3× | −0.8 |
| 2015 | Dec 31, 2015 | 12.1× | – |
See a number that looks wrong?